Nice to see the production royalties are starting to cover most of our staff and administrative costs, which should be ongoing for the next couple of years. Which means more of our capital can be spent drilling the grounds.
- Forums
- ASX - By Stock
- CNB
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-2
Featured News
Add CNB (ASX) to my watchlist
|
|||||
Last
49.0¢ |
Change
0.010(2.08%) |
Mkt cap ! $84.24M |
Open | High | Low | Value | Volume |
46.5¢ | 49.0¢ | 46.5¢ | $43.17K | 89.98K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 13100 | 47.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.0¢ | 45474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 13100 | 0.470 |
3 | 23050 | 0.465 |
4 | 32062 | 0.460 |
1 | 20000 | 0.455 |
2 | 7200 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 45474 | 2 |
0.495 | 20000 | 1 |
0.500 | 51650 | 5 |
0.520 | 1000 | 1 |
0.555 | 1000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
CNB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online